Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis.

Familial cancer·2014

Same author

Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis.

International journal of colorectal disease·2013

Same author

Does preoperative radiotherapy with postoperative chemotherapy increase acute side-effects and postoperative complications of total mesorectal excision? Report of the randomized Finnish rectal cancer trial.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2012

Same author

Risk of cancer in patients with chronic pouchitis after restorative proctocolectomy for ulcerative colitis.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Same author

Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis.

Endoscopy·2009

Same author

Survival of patients with pseudomyxoma peritonei treated by serial debulking.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Search research articles

Related Experiment Video

Updated: May 11, 2026

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 24, 2011

Genetic testing for polyposis: practical and ethical aspects.

H J Järvinen¹

¹Department of Surgery, Helsinki University Central Hospital, Finland. heikki.jarvinen@hus.fi

|March 26, 2003

Summary

Genetic testing for inherited polyposis syndromes enables targeted surveillance for families. Identifying specific mutations allows for personalized care, reducing unnecessary procedures for mutation-negative individuals.

Area of Science:

Genetics
Oncology
Gastroenterology

Background:

Familial adenomatous polyposis, juvenile polyposis, Peutz-Jeghers syndrome, and hereditary non-polyposis colorectal cancer syndrome are inherited polyposis syndromes.
These syndromes predispose individuals to colorectal cancer.
Understanding the genetic basis is crucial for risk assessment and management.

Purpose of the Study:

To highlight the importance of genetic testing in inherited polyposis syndromes.
To emphasize the role of identifying family-specific mutations.
To discuss the implications for surveillance and prophylactic strategies.

Main Methods:

Review of genetic testing protocols for polyposis syndromes.
Analysis of mutation detection rates in affected families.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Related Experiment Videos

Last Updated: May 11, 2026

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 24, 2011

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Evaluation of the impact of genetic testing on clinical management.

Main Results:

Genetic testing can identify pathogenic mutations in 60% to 95% of families with polyposis syndromes.
Mutation-negative family members can safely discontinue endoscopic surveillance.
Targeted surveillance and prophylactic measures can be implemented for mutation-positive individuals.

Conclusions:

Genetic testing is essential for accurate diagnosis and risk stratification in inherited polyposis syndromes.
Personalized surveillance strategies based on genetic findings improve patient outcomes.
National or regional registries are vital for long-term follow-up and management of affected families.